20 AIDX
NASDAQ AIDX
$0.41 0.00 (-1.15%)
As of: Sep 29, 2026 · 3:59 PM EDT

20 (AIDX) Research & Development (2025 - 2026)

Updated

20 (AIDX) posted Research & Development of $257,632 for Q2 2026, up 32.7% from $194,124 a year earlier and up 67.9% from the prior quarter.

Analysis

20 (AIDX) Research & Development (2025 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Research & Development at 20 was $742,069; for FY2025, it was $592,569, down 53.0% from FY2024.

  • In prior years, 20's Research & Development was $1.26 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 HCA Healthcare 94.29 Bn 93.74 Bn - -
2 Natera 59.14 Bn 54.82 Bn 485.19 Mn 228.07 Mn
3 Quest Diagnostics 26.23 Bn 24.66 Bn 1.03 Bn -
4 Labcorp Holdings 25.04 Bn 22.81 Bn 1.11 Bn -
5 Guardant Health 23.69 Bn 19.76 Bn 219.03 Mn 96.53 Mn
6 Tenet Healthcare 20.77 Bn 11.92 Bn - -
7 Tempus AI 14.91 Bn 11.94 Bn 246.50 Mn 52.64 Mn
8 Encompass Health 12.24 Bn 12.70 Bn - -
9 Davita 11.39 Bn 10.15 Bn 1.16 Bn -
10 20 5.02 Mn -6.55 Mn 304,727.00 257,632.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 257,632.00
Mar 31, 2026 153,482.00
Jun 30, 2025 194,124.00
Mar 31, 2025 136,831.00
API Access

20 Research & Development API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=research-and-development&ticker=AIDX&period=max&api_key=YOUR_API_KEY